Netrin-1 disrupts hepatitis B virus attachment and internalization, offering new treatment path

Hepatitis B virus (HBV) infects more than 250 million people worldwide and can lead to chronic liver disease and liver cancer. Current antiviral therapies suppress viral replication but do not eliminate the virus, highlighting the urgent need for…

Continue Reading

News Source: medicalxpress.com